Oxytocin enhancement of fear extinction: A new target for facilitating exposure-based treatments?

Biological Psychiatry

Volumn 78, Issue 3, 2015, Pages 154-155

  Acheson, Dean T ^a,b   Risbrough, Victoria B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; ENDOCANNABINOID; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; OXYTOCIN; OXYTOCIN RECEPTOR;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; ASSOCIATION; BEHAVIOR THERAPY; CONDITIONING; ELECTROENCEPHALOGRAM; EMOTIONALITY; EPIGENETICS; FEAR; FEAR EXTINCTION; HUMAN; LEARNING; MEMORY CONSOLIDATION; NOTE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUBLIC SPEAKING; RECALL; REGULATORY MECHANISM; SOCIAL BEHAVIOR; SOCIAL PHOBIA; VENTROMEDIAL PREFRONTAL CORTEX; AMYGDALA; DRUG EFFECTS; ELECTRODERMAL RESPONSE; MALE; PHYSIOLOGY;

AMYGDALA; FEAR; GALVANIC SKIN RESPONSE; HUMANS; MALE; OXYTOCIN; PREFRONTAL CORTEX;

EID: 84936943097     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.06.002     Document Type: Note

References (10)

1. Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ (2015): Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther 149: 150-190.
2. MacDonald K, Feifel D (2014): Oxytocin's role in anxiety: A critical appraisal. Brain Res 1580: 22-56.
3. Eckstein M, Becker B, Scheele D, Scholz C, Preckel K, Schlaepfer TE, et al. (2015): Oxytocin facilitates the extinction of conditioned fear in humans. Biol Psychiatry 78: 194-202.
4. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, et al. (2005): Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489-11493.
5. Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V (2013): The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology (Berl) 229: 199-208.
6. Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS (2009): A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34: 917-923.
7. Acheson DT, Feifel D, Kamenski M, McKinney R, Risbrough VB (2015): Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depress Anxiety 32: 400-407.
8. Lahoud N, Maroun M (2013): Oxytocinergic manipulations in cortico-imbic circuit differentially affect fear acquisition and extinction. Psychoneuroendocrinology 38: 2184-2195.
9. Bartels A (2012): Oxytocin and the social brain: Beware the complexity. Neuropsychopharmacology 37: 1795-1796.
10. Leng G, Ludwig M (2015): Intranasal oxytocin: Myths and delusions [published online ahead of print May 11]. Biol Psychiatry.